February 2008 Issue of MMM
Like the vast majority of kids growing up in England, I was obsessed with soccer.
The quest to win an MM&M Award starts here with the launch of the 2008 program. As always, your entries will be judged by an ...
What, if anything, is wrong with FDA? And who's to blame: the agency's leadership or its massed ranks of critics? These are just some of ...
The Medical Advertising Hall of Fame will induct Robert Baldini, John Corcoran and Richard Cliggott at a special celebration dinner. The MAHF will also honor ...
New media and technology won't be replacing tried-and-true pharmaceutical direct marketing any time soon say the experts. Stephen McGuire reports on how pharma marketers are ...
She makes house calls, lots of them. Maureen Doyle-Scharff, MBA, FACME, calls Ohio home but logs about half her work hours in Pfizer's Manhattan offices.
A document recently crossed my desk that was so seminal I needed to share it with my colleagues through this column.
Now that we are in a presidential election year, much attention has been directed toward the question of how to extend healthcare to more people.
In Washington, the saying goes, it's not the crime but the cover-up that gets you.
Med Ed Report
UMass Memorial Medical Center has taken a comprehensive approach to limit clinician-industry interaction.
Medical education companies meeting privately with regulators aired their disproval of a new policy they say treats them unfairly, but real parity appeared beyond reach.
The American College of Cardiology (ACC) is examining a policy under which companies requesting space for satellite symposia at its annual meeting must become exhibitors.
Pfizer's goal is to begin posting its CME grants online by the end of March, said Maureen Doyle-Scharff, director, medical education group.
Fission Communications is merging with another McCann Healthcare Worldwide Group property, UK-based Caudex Medical.
"Bias, either by appearance or reality, has become woven into the very fabric of continuing education," noted a report from the Josiah Macy, Jr. Foundation ...
Scienta Healthcare Education, an accredited medical education firm, promoted Sherri Foster to president, from senior vice president and general manager.
Thomson Healthcare has named Mike Boswood president and CEO, replacing Bob Cullen, who is retiring after 23 years at the company.
GlaxoSmithKline said it will shift media buying and planning for its North American OTC brands to WPP's MediaCom by the end of February.
Advanstar named Laura Wagner VP, primary care.
Nature Publishing Group is partnering with Sermo to offer a cross-branded forum for discussion to readers of NPG titles.
Thomson Corp. sold its CenterWatch and New England Institutional Review Board franchises to Jobson Medical Information for an undisclosed sum.
Pink Sheet publisher F-D-C Reports launched PharmAsiaNews, a subscription-based online service covering drugs, devices and biologics in China, India, Japan and other Pacific Rim nations.
Pharma companies that advertise on TV have an eye on the writers' strike, which has hampered Hollywood's ability to churn out new shows and may ...
It looks like 2008 is shaping up to be a difficult year for the industry.
US consumers are turning to the Internet, even more so than their doctors, to research health information, according to a report from digital marketing company ...
Pharma marketers can leverage their brand messages by taking promotional efforts online where users are increasingly searching for healthcare information.
The District of Columbia Council in January approved legislation that would require pharmaceutical sales representatives to obtain licenses to operate within city limits.
Two former Amgen sales reps are suing the company claiming the biotech firm pushed its sales force to search doctor's medical records for potential patients ...
Nitromed announced it plans to lay off a majority of its newly hired BiDil sales force by roughly 70 to 90 employees.
TNS Healthcare named Dennis Callahan VP, sales force effectiveness.
MediZine announced the appointment of James Silverman as VP, sales & marketing.
Publicis Selling Solutions has promoted Lanya Larece to director, client services.
PDI, Inc. announced that it has extended its sales services agreement with a top-10 pharma company through April 2009 to promote its anti-viral medication on ...
Congress is investigating the use of celebrity endorsements in pharmaceutical advertising—starting with a "celebrity doctor," artificial heart inventor Dr. Robert Jarvik.
After all that, Congress has canceled the user fee program for DTC TV ad reviews.
Reps. John Dingell and Bart Stupak aren't only interested in Lipitor advertising.
DTC ads don't offer adequate fair balance, according to a study by the University of Georgia's Grady College of Journalism and Mass Communication.
Consumer drug advertising remains corporate benefit managers' favorite culprit in rising prescription drug costs, according to an Arxcel survey.
The New York Times used the launch of new ads for Pfizer's Lyrica as the peg for an article on fibromyalgia
It's a reflection of our times: if you're in healthcare you must also have political smarts.
Two top pharmas looked outside the industry for their top communications executives
Bowing to outraged patient advocates, NYU Child Study Center said it will halt its controversial print and outdoor ads aimed at raising awareness of mental ...
A Maine law that would have limited access by medical data companies to doctors' prescription information was reversed on constitutional grounds.
IMS Health said it intends to lay off 10% of its workforce, or as many as 760 employees worldwide.
Barely a month after the FDA's Science Board Advisory Committee unanimously declared that "American lives are at risk" because of a growing crisis in the ...
Senator Chuck Grassley (R-IA) has asked the HHS Inspector General to investigate the FDA's troubled approval of the Sanofi-Aventis antibiotic Ketek based exclusively on allegedly ...
Public Citizen has filed a federal court suit asking that the FDA be forced to act on a petition the group says has been unanswered ...
The FDA's Division of Drug Marketing, Advertising, and Communications says a Wyeth professional journal ad for Effexor XR (venlaxine HCl) tablets was misleading because it ...
Former FDA commissioner David A. Kessler, who refused to allow DTC advertising during his term, has been fired from his $540,000-a-year position as dean of ...
Congressmen Mike Michaud (R-ME), Dan Burton (R-IN) and Tim Ryan (D-OH) wrote House Energy and Commerce calling for a hearing to examine alleged conflicts of ...
Sen. Herb Kohl (D-WI) has asked commissioner Andrew von Eschenbach for info relating to the FDA's role in a decision by Genentech to limit availability ...
The government says the US Supreme Court should wait before deciding whether to hear an appeal of a Vermont Supreme Court decision in a product ...
Success! When Congress was debating the new Medicare drug benefit, the pharmaceutical industry's top priority was to make sure the government could not negotiate prescription ...
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.